Process for improving flow characteristics of crystalline ibuprofen
AssigneeAlbemarle Corporation
InventorsLloyd E. Goddard, George A. Knesel
Life of this patent
Estimating the term…
Abstract
A process for producing crystalline ibuprofen having a crystal habit characterized by a particle length larger than 75 microns average and a length to width aspect ratio of greater than about 4 to 1 to about 5 to 1. The process involves crystallizing ibuprofen from a saturated solution of ibuprofen in a liquid hydrocarbon solvent by seeding and cooling such solution to a temperature of about 0.degree. C. to about -20.degree. C. at a rate to retard primary nucleation and promote secondary nucleation. The crystalline ibuprofen is separated from the slurry produced from such cooling.
Claims12
In a process for preparing crystalline ibuprofen by forming a saturated solution of ibuprofen in a hydrocarbon solvent seeding such saturated solution with solid ibuprofen;
- and cooling the seeded saturated solution below the saturation point to effect crystallization and precipitating the crystalline ibuprofen from the solution thereof, the improvement comprising
- (a) carrying out said cooling by reducing the temperature of said saturated solution in three sequential steps by about 5% in each step and holding said reduced temperature for about 10 minutes to about 180 minutes for each of said three sequential steps then reducing the temperature of the solution resulting from the third sequential step to about 0.degree. to about -20.degree., and
- (b) precipitating crystalline ibuprofen having a crystal habit characterized by having a particle length larger than 150 microns average and a length to width aspect ratio of from about 4.1 to 1 to about 5 to 1.
The process according to claim 12 where each of said three sequentially lower temperatures is carried out over an interval of from about 45 minutes to about 75 minutes.
Dependencies are inferred from the claim text.